Gelatinolytic activity of matrix metalloproteinase‐2 and matrix metalloproteinase‐9 in rat brain after implantation of 9L rat glioma cells

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Neurology

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1468-1331.2006.01705.xPMID 17437609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression

  2006cited by this paper
• Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomas

  2006cited by this paper
• The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades

  2006cited by this paper
• Localization of gelatinase activities in glioma tissues by film in situ zymography

  2006cited by this paper
• Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas.

  2005cited by this paper
• Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.

  2005cited by this paper
• Recombinant Sendai Virus Vector Induces Complete Remission of Established Brain Tumors through Efficient Interleukin-2 Gene Transfer in Vaccinated Rats

  2005cited by this paper
• Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.

  2003cited by this paper
• The role of matrix metalloproteinases in glioma invasion.

  2003cited by this paper
• Distinct Expression Patterns and Levels of Enzymatic Activity of Matrix Metalloproteinases and Their Inhibitors in Primary Brain Tumors

  2001cited by this paper
• Functional Interplay between Type I Collagen and Cell Surface Matrix Metalloproteinase Activity*

  2001cited by this paper
• Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma; a study using in situ zymography.

  2000cited by this paper
• Suppression of Cell Invasion on Human Malignant Glioma Cell Lines by a Novel Matrix-metalloproteinase Inhibitor SI-27: In Vitro Study

  2000cited by this paper
• Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas.

  2000cited by this paper
• Matrix metalloproteinases and their biological function in human gliomas

  1999cited by this paper
• Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas

  1999cited by this paper
• Matrix metalloproteinases and metastasis

  1999cited by this paper
• Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours.

  1998cited by this paper
• Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.

  1996cited by this paper
• Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis

  1995cited by this paper
• Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.

  1995cited by this paper
• Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.

  1994cited by this paper
• Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay

  1992cited by this paper
• Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

  1985cited by this paper
• Is cell survival a determinant of the in situ response of 9L tumours?

  1980cited by this paper
• Metastatic potential correlates with enzymatic degradation of basement membrane collagen

  1980cited by this paper

• MMP-2 AND NGAL AS BIOMARKERS IN GLIOBLASTOMA: A PILOT STUDY

  2019cites this paper
• MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma

  2019cites this paper
• MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma

  2019cites this paper
• RETRACTED: Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine

  2015cites this paper
• CRM197 in Combination With shRNA Interference of VCAM‐1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells

  2015cites this paper
• Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma

  2014cites this paper
• Polish Natural Bee Honeys Are Anti-Proliferative and Anti-Metastatic Agents in Human Glioblastoma multiforme U87MG Cell Line

  2014cites this paper
• Artemether Combined with shRNA Interference of Vascular Cell Adhesion Molecule-1 Significantly Inhibited the Malignant Biological Behavior of Human Glioma Cells

  2013cites this paper
• Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo

  2012cites this paper
• Establishing the validity of glycoursodeoxycholic acid as a coadjuvant of temozolomide therapy in gliomas

  2012cites this paper
• The Role of Matrix Metalloproteinases a nd Tissue Inhibitors of Metalloproteinases in the Progression of Astrocytomas

  2011cites this paper
• Trafficking and secretion of matrix metalloproteinase‐2 in olfactory ensheathing glial cells: A role in cell migration?

  2011cites this paper
• TLR4 signal transduction pathways neutralize the effect of Fas signals on glioblastoma cell proliferation and migration.

  2011cites this paper
• Assays for determination of matrix metalloproteinases and their activity

  2011cites this paper
• Clinical importance of matrix metalloproteinases.

  2011cites this paper
• Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors.

  2010cites this paper
• Pediatric brain tumors.

  2009cites this paper
• Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy

  2009cites this paper
• Neurotoxic activity and ultrastructural changes in muscles caused by the brown widow spider Latrodectus geometricus venom.

  2009cites this paper
• The regulating role of mutant I&kgr;B&agr; in expression of TIMP‐2 and MMP‐9 in human glioblastoma multiform

  2009cites this paper
• The regulating role of mutant IkappaBalpha in expression of TIMP-2 and MMP-9 in human glioblastoma multiform.

  2009cites this paper
• Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy

  2008cites this paper
• Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc.

  2008cites this paper
• Antitumor and antimetastatic actions of anthrone‐C‐glucoside, cassialoin isolated from Cassia garrettiana heartwood in colon 26‐bearing mice

  2008cites this paper
• Antitumor activities of synthetic and natural stilbenes through antiangiogenic action

  2008cites this paper
• Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study

  2007cites this paper
• Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.

  2007cites this paper